The first and only hydroxyurea-based treatment for pediatric patients with sickle cell anemia, now available in 100 mg scored tablets to help further optimize dosing

Read more

DR. COREY HEBERT HOSTS A FOUR-PART VIDEO SERIES ON “WHAT YOU NEED TO KNOW ABOUT SICKLE CELL ANEMIA”

Read more

On World Sickle Cell Day, Medunik USA highlights the importance of early treatment of Sickle Cell Disease

Read more

Medunik USA expands access to the first and only prescription medication for pediatric sickle cell anemia patients by offering 340B pricing to covered entities through Apexus.

Read more

Medunik USA announces two savings programs that allow families affected by sickle cell disease to pay as little as $0 for their child’s prescription

Read more